CRH Medical Corp (NYSEARCA:CRHM) Upgraded to Sector Outperform at Scotiabank

CRH Medical Corp (NYSEARCA:CRHM) was upgraded by equities researchers at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a report issued on Monday, July 24th.

Other analysts have also issued research reports about the stock. Canaccord Genuity reissued a “buy” rating and issued a $8.00 price objective on shares of CRH Medical Corp in a research report on Monday, July 17th. Zacks Investment Research raised shares of CRH Medical Corp from a “sell” rating to a “hold” rating in a research report on Tuesday, May 2nd. TD Securities lowered shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a research report on Tuesday, July 18th. Royal Bank Of Canada raised shares of CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a research report on Friday, July 21st. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price objective (up previously from $8.00) on shares of CRH Medical Corp in a research report on Monday, March 27th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $8.13.

CRH Medical Corp (CRHM) remained flat at $2.60 during midday trading on Monday. The company had a trading volume of 71,575 shares. CRH Medical Corp has a 52 week low of $2.14 and a 52 week high of $9.25. The company’s 50-day moving average is $3.64 and its 200-day moving average is $6.04.

WARNING: “CRH Medical Corp (NYSEARCA:CRHM) Upgraded to Sector Outperform at Scotiabank” was originally published by BNB Daily and is the sole property of of BNB Daily. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/19/crh-medical-corp-nysearcacrhm-upgraded-to-sector-outperform-by-scotiabank-updated-updated-updated.html.

Hedge funds have recently bought and sold shares of the company. ARP Americas LLC raised its position in shares of CRH Medical Corp by 7.4% in the first quarter. ARP Americas LLC now owns 13,042 shares of the company’s stock valued at $107,000 after buying an additional 900 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of CRH Medical Corp by 15,344.4% in the first quarter. Tower Research Capital LLC TRC now owns 13,900 shares of the company’s stock valued at $114,000 after buying an additional 13,810 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of CRH Medical Corp during the first quarter valued at $150,000. KCG Holdings Inc. raised its position in shares of CRH Medical Corp by 40.1% in the first quarter. KCG Holdings Inc. now owns 19,486 shares of the company’s stock valued at $160,000 after buying an additional 5,579 shares during the last quarter. Finally, Navellier & Associates Inc bought a new position in shares of CRH Medical Corp during the first quarter valued at $198,000.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply